Latest research shows Australia on track to cure Hepatitis C

Kirby Institute/UNSW – 21 February 2017

More Australians were treated for their hepatitis C infection in the first year new generation hepatitis C regimens were made available on the Pharmaceutical Benefits Schemes than in the past decade, according to a new report released today by the Kirby Institute at UNSW Sydney.

 

New Treatments for Hepatitis C: the facts

Hepatitis NSW, 2016

This is a really exciting time if you live in Australia and have hep C. The Federal government has announced that new direct acting antiviral (DAA) treatment drugs will be free and available to you from 1 March 2016.

The new treatments are:

  • Harvoni® (sofosbuvir/ledipasvir) two drugs combined in each pill
  • Sovaldi® and Daklinza® (sofosbuvir and daclatasvir) separate pills, taken together
  • Sovaldi® and Ibavyr® (sofosbuvir and ribavirin) separate pills, taken together

Other new drugs for treating hep C are under development and in the approval process. These new drugs will probably be also made available.

Read more here